Despite a record jump in revenue, Netflix still failed to satisfy investors after announcing today that it had lost more than 800,000 subscribers in the past quarter, and will go into the red during the fourth quarter to pay for international growth.More >>
The Food and Drug Administration says it has approved a new drug from Biogen Idec to control multiple sclerosis in adults with hard-to-treat forms of the disease.
The twice-a-day capsules, called Tecfidera offer a new option for multiple sclerosis, a debilitating disease in which the body attacks its own nervous system. Cambridge, Massachusetts-based Biogen Idec already sells two other drugs for the disease, but both require injections.
The FDA says it approved Tecfidera based on two studies showing patients taking the drug had fewer relapses than patients taking a dummy pill.
The approval gives Biogen a new product in an increasingly crowded field of multiple sclerosis drugs.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)